BioNTech SE (BNTX)
BioNTech SE Free Cash Flow margin
| Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow margin | 0.0% | (179.1%) | (98.8%) | (248.3%) | (20.5%) | 3.9% | 76.3% | 122.2% |
BioNTech SE (BNTX) Free Cash Flow margin comparison analysis
BNTX key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is BioNTech SE's Free Cash Flow margin?
As of today, Microsoft Corp's last 12-month Free Cash Flow margin is 32.4%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Free Cash Flow margin for BioNTech SE have been 57.2% over the past three years, and (11.4%) over the past five years.
2) Is BioNTech SE's Free Cash Flow margin Good?
As of today, BioNTech SE's Free Cash Flow margin is 32.4%, which is higher than industry median of (753.4%). It indicates that BioNTech SE's Free Cash Flow margin is Good.